Robotic-assisted urological surgery outcomes study
Part of Kidney & urinary clinical trials.
This study looks at how well robotic-assisted surgery works for urological conditions. It may help doctors understand the benefits and risks of this type of surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had surgery for a urological condition (like prostate, kidney, or bladder issues).
- The surgery was done with the help of a robotic system.
- You are 18 years old or older.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the results of robot-assisted surgeries in children to learn how safe and effective they are. It focuses on surgeries done in 2025 at one children's hospital.
This study collects health information from men who have had robotic surgery for prostate cancer. It aims to learn more about the outcomes of this surgery to help improve future care.
This trial studies a specific robotic surgical system during abdominal and pelvic surgeries. It may help doctors improve how these operations are done using minimally invasive techniques (smaller cuts).
This study looks at ways to improve how surgeons perform during robot-assisted surgeries. If you are a surgeon who does robotic procedures, joining this study could help make surgery safer and more effective.
This study is testing a new robotic surgery system called da Vinci SP for urologic (urinary tract and male reproductive) surgeries. It aims to see how well it works for conditions like prostate, kidney, and bladder problems.
This trial tests the Versius robotic system for minimally invasive urology surgery in children under 18. It may help young patients have a less invasive procedure with a smaller incision and faster recovery.
Hear when a new Outcome Assessment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.